Trial Profile
A dose-escalation, Phase I trial of RP-1000
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2022
Price :
$35
*
At a glance
- Drugs BX 1000 (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- 16 Mar 2022 Status changed from active, no longer recruiting to completed, according to a Baudax Bio media release.
- 11 Nov 2021 According to a Baudax Bio media release, Baudax is preparing the clinical study report for this dose-escalation study and expects to submit it to FDA early in the New Year
- 11 Nov 2021 Status changed from recruiting to active, no longer recruiting according to a Baudax Bio media release